K181229 is an FDA 510(k) clearance for the TirboLOX-C Cervical IBFD. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).
Submitted by Captiva Spine, Inc. (Jupiter, US). The FDA issued a Cleared decision on September 19, 2018, 133 days after receiving the submission on May 9, 2018.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..